UMIN ID: UMIN000050732
Registered date:31/03/2023
A web-based survey on itching in patients with seasonal allergic conjunctivitis in 2023
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | seasonal allergic conjunctivitis |
Date of first enrollment | 2023/03/31 |
Target sample size | 1000 |
Countries of recruitment | Japan |
Study type | Others,meta-analysis etc |
Intervention(s) |
Outcome(s)
Primary Outcome | The situation of eye itch The relationship between eye itch and eye drop behavior |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 18years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Medical professionals (doctors, pharmacists, nurses, etc.) Subjects engaged in pharmaceuticals and medical devices industry Subjects engaged in pharmaceuticals distributor Subjects engaged in information provision services, research services, and advertising Subjects with severe allergic conjunctival disease (vernal keratoconjunctivitis , atopic keratoconjunctivitis) |
Related Information
Primary Sponsor | Santen Pharmaceutical Co., Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Santen Pharmaceutical Co., Ltd. |
Secondary ID(s) |
Contact
public contact | |
Name | Hirotsugu Kishimoto |
Address | 4-20, Ofukacho, Kita-ku, Osaka Japan 5308552 |
Telephone | 06-4802-9337 |
clinical@santen.co.jp | |
Affiliation | Santen Pharmaceutical Co., Ltd. Japan Medical Affairs Group |
scientific contact | |
Name | Reiko Miyahara |
Address | 4-20, Ofukacho, Kita-ku, Osaka Japan |
Telephone | 06-4802-9337 |
clinical@santen.co.jp | |
Affiliation | Santen Pharmaceutical Co., Ltd. Japan Medical Affairs Group |